483 Wuxi Fortune Pharmaceutical Jul 2017

483 Wuxi Fortune Pharmaceutical Jul 2017

Samantha Bradley FDA$119.00 - Available Now

FDA investigators audited the Wuxi Fortune Pharmaceutical - Wuxi, China facility and issued inspectional observations (via FDA 483) on 28 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Jul 2017
  • Location: Wuxi, China
  • FEI: 3005968356
Add To Cart